Executive Council

Board of Management (Kemal Malik, Dieter Weinand, Werner Baumann, Dr. Hartmut Klusik, Dr. Marijn Dekkers, Johannes Dietsch, Erica Mann, Liam Condon) (Photo)

Kemal Malik, Dieter Weinand, Werner Baumann, Dr. Hartmut Klusik, Dr. Marijn Dekkers, Johannes Dietsch, Erica Mann, Liam Condon

On January 1, 2016, the Board of Management of Bayer AG was enlarged to include the heads of the Pharmaceuticals, Consumer Health and Crop Science divisions. Management of the company has thus been aligned more strongly with business operations.

Kemal Malik

Innovation · Latin America region

Kemal Malik studied medicine and worked in a London hospital. After holding different positions of increasing responsibility at Bristol-Myers Squibb, he joined Bayer in 1995. In 2007 Malik became a member of the Executive Committee, head of Global Development and Chief Medical Officer of Bayer HealthCare. He was appointed to the Bayer Board of Management in February 2014.

Dieter Weinand

Pharmaceuticals · North America region

Dieter Weinand studied pharmacology, toxicology and biology in New York. After holding positions at various companies in the pharmaceutical industry including Pfizer and Bristol-Myers Squibb, he was President Global Commercialization & Portfolio Management at Otsuka Pharmaceutical Development & Commercialization Inc. in Princeton. In 2014, Weinand became President of the Pharmaceuticals Division at Bayer. He was appointed to the Bayer Board of Management in January 2016.

Werner Baumann1

Strategy and Portfolio Management · Europe / Middle East / Africa region

Werner Baumann studied economics in Aachen and Cologne, joining Bayer AG in 1988. After holding positions of increasing responsibility in Spain and the United States, he became a member of the Board of Management of Bayer HealthCare. He was appointed to the Bayer Board of Management in 2010, first as Chief Financial Officer and then as Chief Strategy and Portfolio Officer. He was additionally appointed Chief Executive Officer of Bayer HealthCare in 2015.

Dr. Hartmut Klusik*

Human Resources · Technology and Sustainability

Hartmut Klusik studied chemistry in Marburg. After gaining a Ph.D, he began his professional career at Wolff Walsrode in 1984. He transferred to crop protection production at Bayer in Brazil in 1990. Following assignments in the United States and Australia and after holding positions of increasing responsibility at Bayer CropScience, he was appointed to the Board of Management of Bayer HealthCare with responsibility for Product Supply. He was appointed to the Bayer Board of Management in January 2016.

* Labor Director

Dr. Marijn Dekkers1

Chief Executive Officer of Bayer

Marijn Dekkers studied chemistry and chemical engineering in Nijmegen and Eindhoven. After gaining a Ph.D., he began a career in research with General Electric in the United States. Having held various positions in the United States, latterly as Chief Executive Officer and President of Thermo Fisher Scientific Inc., Dekkers took over as Chief Executive Officer of Bayer in October 2010.

Johannes Dietsch

Chief Financial Officer of Bayer · Asia / Pacific region

Johannes Dietsch completed his training with Bayer as a commercial assistant and business administrator in 1984. He subsequently held various managerial positions within the company, including one in Japan. In 2002, Dietsch took over as head of the Finance Department in the Corporate Center. He became Senior Bayer Representative and CFO of Bayer in China in 2011. He was appointed to the Bayer Board of Management in September 2014.

Erica Mann

Consumer Health

Erica Mann holds a degree in analytical chemistry and a marketing diploma from her studies in Johannesburg, South Africa. She began her career with Eli Lilly & Company and held positions at Johnson & Johnson, Lederle Laboratories and Wyeth before moving into senior management at Pfizer in the United States. She became head of Consumer Care at Bayer HealthCare in 2011. She was appointed to the Bayer Board of Management in January 2016.

Liam Condon

Crop Science

Liam Condon studied international marketing in Dublin and Berlin. He held various positions of increasing responsibility with the former Schering AG, Berlin, Germany, and with Bayer HealthCare in Europe and Asia, including Managing Director of Bayer HealthCare China and head of Bayer HealthCare in Germany. Condon became Chief Executive Officer of Bayer CropScience in 2012. He was appointed to the Bayer Board of Management in January 2016.

1 Effective May 1, 2016, Werner Baumann will become the new Chairman of the Board of Management of Bayer AG. Dr. Marijn Dekkers will leave the company at his own request on April 30, 2016.